Supernus Pharmaceuticals (S49) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

1 Followers

Earnings Data

Report Date

Nov 10, 2026

After Close (Confirmed)

Period Ending

2026 (Q3)

Consensus EPS Forecast

0.5

Last Year’s EPS

0.81

Same Quarter Last Year

Strong Buy

Based on 5 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:S49 Upcoming Earnings

Supernus Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2026	2026 (Q3)	0.50 / -	0.813	―	―	―
Aug 03, 2026	2026 (Q2)	0.34 / 0.43	0.734	-42.07% (-0.31)
May 05, 2026	2026 (Q1)	0.24 / 0.49	0.354	37.44% (+0.13)	―
Feb 24, 2026	2025 (Q4)	0.27 / 0.68	0.603	13.40% (+0.08)	―
Nov 04, 2025	2025 (Q3)	0.48 / 0.81	0.945	-13.96% (-0.13)	―
Aug 05, 2025	2025 (Q2)	0.38 / 0.73	0.624	17.77% (+0.11)	―
May 06, 2025	2025 (Q1)	0.30 / 0.35	0.372	-4.78% (-0.02)	―
Feb 25, 2025	2024 (Q4)	0.42 / 0.60	0.714	-15.52% (-0.11)	―
Nov 04, 2024	2024 (Q3)	0.36 / 0.94	-0.235	502.76% (+1.18)	―
Aug 06, 2024	2024 (Q2)	0.32 / 0.62	-0.016	3955.00% (+0.64)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Supernus Pharmaceuticals (CH:S49) report earnings?

Supernus Pharmaceuticals (CH:S49) is schdueled to report earning on Nov 10, 2026, After Close (Confirmed).

What is Supernus Pharmaceuticals (CH:S49) earnings time?

Supernus Pharmaceuticals (CH:S49) earnings time is at Nov 10, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Supernus Pharmaceuticals stock?

The P/E ratio of Supernus Pharmaceuticals is N/A.

What is CH:S49 EPS forecast?

CH:S49 EPS forecast for the fiscal quarter 2026 (Q3) is 0.5.